Table 2.
The results of multivariable linear regression analysis in patients with williams syndrome and control subjectsa.
| Iris grading | ||||||
|---|---|---|---|---|---|---|
| Grade I | Grade II | Grade III | ||||
| β Coefficient (95% CI) | P Value | β Coefficient (95% CI) | P Value | β Coefficient (95% CI) | P Value | |
| LogMAR BCVA | 0.03 [−0.06–0.11] | 0.543 | 0.03 [−0.06–0.12] | 0.472 | 0.02 [−0.07–0.11] | 0.693 |
| Vessel Density | −2.67 [−4.97–−0.38] | 0.024 | −3.52 [−6.57–−0.47] | 0.025 | 0.17 [−2.63–2.96] | 0.905 |
| Vessel Density-Fovea | −7.20 [−12.41–−2.00] | 0.008 | −10.20 [−17.12–−3.27] | 0.005 | −2.15 [−8.48–4.19] | 0.496 |
| Foveal Avascular Zone | 0.11 [0.01–0.21] | 0.033 | 0.20 [0.07–0.34] | 0.005 | 0.03 [−0.10–0.16] | 0.586 |
| Central Macular Thickness | −17.29 [−31.48–−3.11] | 0.018 | −29.46 [−44.26–−14.66] | <0.001 | −21.68 [−37.08–−6.28] | 0.007 |
| Fovea Upper Width | 98.35 [34.58–162.11] | 0.003 | 127.08 [57.07–197.10] | 0.001 | 36.96 [−32.22–106.15] | 0.288 |
| Fovea Lower Width | 128.69 [80.60–176.77] | <0.001 | 132.91 [80.12–185.71] | <0.001 | 84.30 [32.13–136.47] | 0.002 |
| Arterial Outer Diameter | −17.04 [−24.26–−9.82] | <0.001 | −7.48 [−15.31–0.36] | 0.061 | −20.04 [−27.72–−12.36] | <0.001 |
| Arterial Inner Diameter | −15.55 [−22.09–−9.00] | <0.001 | −6.26 [−13.37–0.84] | 0.082 | −18.16 [−25.13–−11.19] | <0.001 |
| Arterial Vessel Wall | −0.81 [−1.75–0.14] | 0.091 | −0.85 [−1.87–0.18] | 0.102 | −0.93 [−1.93–0.08] | 0.069 |
| Venous Outer Diameter | −11.00 [−18.73–−3.26] | 0.007 | −9.39 [−18.60–−0.17] | 0.046 | −21.84 [−30.89–−12.80] | <0.001 |
| Venous Inner Diameter | −12.77 [−21.21–−4.33] | 0.004 | −7.47 [−17.53–2.59] | 0.141 | −26.05 [−35.93–−16.18] | <0.001 |
| Venous Vessel Wall | 1.01 [−0.37–2.39] | 0.147 | −0.73 [−2.37–0.91] | 0.373 | 0.66 [−0.96–2.27] | 0.413 |
logMAR logarithm of the Minimum Angle of Resolution, BCVA best corrected visual acuity, CI confidence interval.
aAdjusting for Age and Gender, subjects with iris grade 0 were used as controls.